Evidence map›Paper›PMID 30371329›Full record

Trial reportJournal of the American Heart Association2018

Remote Ischemic Preconditioning Acutely Improves Coronary Microcirculatory Function.

Jerrett K Lau, Probal Roy, Ashkan Javadzadegan, Abouzar Moshfegh, William F Fearon, Martin Ng, Harry Lowe, David Brieger, Leonard Kritharides, Andy S Yong

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04779008 (Long-term Remote Ischemic Preconditioning Improves Myocardial Perfusion and Prognosis of Patients After Coronary Artery Bypass Grafting), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04779008 narecruitingnot on this mapstarted 2021, after this paper: background citation

Long-term Remote Ischemic Preconditioning Improves Myocardial Perfusion and Prognosis of Patients After Coronary Artery Bypass Grafting

TypeinterventionalSponsorHenan Institute of Cardiovascular EpidemiologyRan2021 to 2026Enrolled210ConditionsCoronary DiseaseArmsremote ischemic preconditioning (RIPC)
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Effects of remote ischemic preconditioning and/or erythropoietin on lung injury induced by skeletal ischemia reperfusion: role of the NLRP3 inflammasome.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  8. Promoting Resiliency to Stress in the Vascular Endothelium.Basic & clinical pharmacology & toxicology · 2025
    Review
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Hydrogen sulfide restores cardioprotective effects of remote ischemic preconditioning in aged ratsThe Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Jerrett K Lau1 Concord Repatriation General Hospital University of Sydney Australia.
Probal Roy1 Concord Repatriation General Hospital University of Sydney Australia.
Ashkan Javadzadegan2 ANZAC Research Institute University of Sydney Australia.
Abouzar Moshfegh2 ANZAC Research Institute University of Sydney Australia.
William F Fearon5 Division of Cardiovascular Medicine Stanford University School of Medicine Stanford CA.
Martin Ng3 Department of Cardiology Royal Prince Alfred Hospital University of Sydney Australia.
Harry Lowe1 Concord Repatriation General Hospital University of Sydney Australia.
David Brieger1 Concord Repatriation General Hospital University of Sydney Australia.
Leonard Kritharides1 Concord Repatriation General Hospital University of Sydney Australia.
Andy S Yong1 Concord Repatriation General Hospital University of Sydney Australia.
Anzac Research Institute · AUConcord Repatriation General Hospital · AUMacquarie University · AUUniversity of Sydney · AURoyal Prince Alfred Hospital · AUStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Remote ischemic preconditioning (RIPC) attenuates myocardial damage during elective and primary percutaneous coronary intervention. Recent studies suggest that coronary microcirculatory function is an important determinant of clinical outcome. The aim of this study was to assess the effect of RIPC on markers of microcirculatory function. Methods and Results Patients referred for cardiac catheterization and fractional flow reserve measurement were randomized to RIPC or sham. Operators and patients were blinded to treatment allocation. Comprehensive physiological assessments were performed before and after RIPC/sham including the index of microcirculatory resistance and coronary flow reserve after intracoronary glyceryl trinitrate and during the infusion of intravenous adenosine. Thirty patients were included (87% male; mean age: 63.1±10.0 years). RIPC and sham groups were similar with respect to baseline characteristics. RIPC decreased the calculated index of microcirculatory resistance (median, before RIPC: 22.6 [interquartile range [IQR]: 17.9-25.6]; after RIPC: 17.5 [IQR: 14.5-21.3]; P=0.007) and increased coronary flow reserve (2.6±0.9 versus 3.8±1.7, P=0.001). These RIPC-mediated changes were associated with a reduction in hyperemic transit time (median: 0.33 [IQR: 0.26-0.40] versus 0.25 [IQR: 0.20-0.30]; P=0.010). RIPC resulted in a significant decrease in the calculated index of microcirculatory resistance compared with sham (relative change with treatment [mean±SD] was -18.1±24.8% versus +6.1±37.5; P=0.047) and a significant increase in coronary flow reserve (+41.2% [IQR: 20.0-61.7] versus -7.8% [IQR: -19.1 to 10.3]; P<0.001). Conclusions The index of microcirculatory resistance and coronary flow reserve are acutely improved by remote ischemic preconditioning. This raises the possibility that RIPC confers cardioprotection during percutaneous coronary intervention as a result of an improvement in coronary microcirculatory function. Clinical Trial Registration URL: www.anzctr.org.au/ . Unique identifier: CTRN12616000486426.

Indexed as

Coronary Artery DiseaseCoronary CirculationCoronary VesselsElective Surgical ProceduresElectrocardiographyFemaleHumansIntraoperative PeriodIschemic Preconditioning, MyocardialMaleMicrocirculationMiddle AgedPercutaneous Coronary InterventionVascular Resistancecoronary flow reservecoronary physiologymicrocirculationmicrocirculatory resistanceremote ischemic preconditioning

Identifiers

PMID30371329
PMCPMC6404904
OpenAlexW2894192335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.